Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Lung Cancer

Free Subscription 12.10.2026 3 BMC Cancer 2 Cancer 1 Cancer Epidemiol Biomarkers Prev 1 Cancer Lett 1 Carcinogenesis 4 Chest 1 Clin Exp Metastasis 2 Clin Lung Cancer 3 Clin Nucl Med 1 Eur J Cancer 1 Int J Cancer 1 Int J Oncol 1 J Natl Cancer Inst 2 Nat Genet 4 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Cancer

1. SHAO X, Sun Y, Gao J, Ge X, et al
   Comparison of radiomics handcrafted features and deep features in (18)F-FDG PET/CT for differentiating benign and malignant persistent pulmonary ground-glass nodules.
   BMC Cancer. 2026;26:1184.
   PubMed         Abstract available
   
   
2. YANG L, Guo C, Du X, Li S, et al
   Stage-dependent prognostic value of clinical and pathological T staging in resected lung adenocarcinoma: a multicenter cohort study.
   BMC Cancer. 2026;26:1205.
   PubMed         Abstract available
   
   
3. ZHANG N, Liu J, Han J, Liu J, et al
   Despite improved overall stratification, the 9th edition stage IIIA category remains prognostically heterogeneous: insights from a T3N2a subgroup analysis.
   BMC Cancer. 2026;26:1199.
   PubMed         Abstract available
   
   

   
   Cancer

4. HAYNES D, Jeon J, Silvestri G, Lambert C, et al
   Who is eligible for lung cancer screening, and where are they? National subpopulation estimates of people eligible for lung cancer screening.
   Cancer. 2026;132:e70634.
   PubMed         Abstract available
   
   
5. CANASLAN K, Pan K, Leal T
   Redefining leptomeningeal metastasis in non-small cell lung cancer: From terminal complication to molecularly managed disease.
   Cancer. 2026;132:e70624.
   PubMed         Abstract available
   
   

   
   Cancer Epidemiol Biomarkers Prev

6. LI Z, Zhang Z, Zhao YC, Su L, et al
   Lung Function-Associated Genetic Variants and Overall Survival in Non-Small Cell Lung Cancer: A Multi-Platform Analysis.
   Cancer Epidemiol Biomarkers Prev. 2026 Oct 6. doi: 10.1158/1055-9965.EPI-26-0739
   PubMed         Abstract available
   
   

   
   Cancer Lett

7. YAO Y, Wang X, Yin E, Yang Z, et al
   KEAP1 loss-of-function suppresses immunogenic ferroptosis and limits PD-1 blockade efficacy through an NRF2-FSP1 pathway.
   Cancer Lett. 2026;660:218838.
   PubMed         Abstract available
   
   

   
   Carcinogenesis

8. GAO YY, Xu JJ, Wu YX, Xu HM, et al
   Air pollution and early-onset lung cancer: from environmental carcinogenesis to early intervention strategies.
   Carcinogenesis. 2026 Oct 5:bgag070. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Chest

9. ASSADI M, Juweid ME, Jonigk DD, Spillner J, et al
   PET Molecular Imaging and Theranostics in Lung Diseases: Making Precision Medicine a Reality.
   Chest. 2026;170:1187-1199.
   PubMed         Abstract available
   
   
10. KALSI HS, Khan R, Nimako K, Khiroya R, et al
    Nodular Fasciitis of the Lung: A Novel Entity.
    Chest. 2026;170:e113-e116.
    PubMed         Abstract available
    
    
11. BADER JM, Prince SR, de Santis W, Kane ER, et al
    Natural History, Treatment, Survival, and Causes of Mortality in Patients With Subsolid and Ground-Glass Nodules.
    Chest. 2026;170:1326-1336.
    PubMed         Abstract available
    
    
12. HE F, Xu Y, Tu B, Liu Y, et al
    Lung Cancer Screening Beyond Smoking-Based Eligibility: Evidence, Limits, and Lessons From China.
    Chest. 2026 Oct 5:S0012-3692(26)06781-4. doi: 10.1016/j.chest.2026.
    PubMed         Abstract available
    
    

    
    Clin Exp Metastasis

13. LI J, Shi Y, Ju S, Jiang D, et al
    Transcriptional activation of EPHB1 by SOX2 promotes epithelial-mesenchymal transition and metastasis in esophageal squamous cell carcinoma.
    Clin Exp Metastasis. 2026;43:51.
    PubMed         Abstract available
    
    

    
    Clin Lung Cancer

14. GHOSH S, Chen Y, Le HH, Ashaye A, et al
    Comparative Effectiveness of First-Line Tyrosine Kinase Inhibitors in ALK-Positive Metastatic Non-Small Cell Lung Cancer by Presence of Brain Metastases.
    Clin Lung Cancer. 2026;27:11-19.
    PubMed         Abstract available
    
    
15. LALLA M, Du S, Gor R, Narvel H, et al
    Low Baseline Absolute Neutrophil Count and Chemotherapy Safety in African American Patients with Advanced Lung Cancer: A Retrospective Cohort Study.
    Clin Lung Cancer. 2026;27:20-24.
    PubMed         Abstract available
    
    

    
    Clin Nucl Med

16. ZHU L, Peng L, Liu F, Zhou L, et al
    Intestine as the Exclusive Site of Distant Metastasis From Lung Adenocarcinoma Detected on 18F-FDG PET/CT.
    Clin Nucl Med. 2026 Aug 13. doi: 10.1097/RLU.0000000000006662.
    PubMed         Abstract available
    
    
17. CHUA VSL, Chua WM, Tang CYL
    Primary Pulmonary Diffuse Large B-cell Lymphoma.
    Clin Nucl Med. 2026;51:e1062-e1064.
    PubMed         Abstract available
    
    
18. XU Q, Wu H, Zhong J, He Y, et al
    18F-FDG PET/CT Imaging of a Rare Rectal Extraluminal Metastasis From Pulmonary Sarcomatoid Carcinoma.
    Clin Nucl Med. 2026 Jun 12. doi: 10.1097/RLU.0000000000006573.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

19. TANCREDI S, Chiolero A
    Response to the letter RE: Assessing the magnitude of surveillance bias in prostate cancer, melanoma and lung cancer.
    Eur J Cancer. 2026;248:117077.
    PubMed        
    
    

    
    Int J Cancer

20. ZHENG S, Jia W, Jing X, Tian Y, et al
    Reassessing the Incidence and Risk Factors of Radiation Pneumonitis in Treatment-Naive EGFR-Mutant NSCLC With Concurrent Third-Generation EGFR-TKI and Thoracic Radiotherapy.
    Int J Cancer. 2026;159:2791-2803.
    PubMed         Abstract available
    
    

    
    Int J Oncol

21. WANG L, Ruan C
    Regulatory T cells in lung adenocarcinoma: Mechanisms of immune escape, prognostic significance and therapeutic opportunities (Review).
    Int J Oncol. 2026;69:130.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

22. PURJA S, Kim E
    Adaptive design increased success but does not significantly accelerate confirmatory oncology trials.
    J Natl Cancer Inst. 2026;118:1888-1898.
    PubMed         Abstract available
    
    

    
    Nat Genet

23. 
    Loss of lineage fidelity underpins drug resistance in Kras-mutant lung cancer.
    Nat Genet. 2026;58:2433-2434.
    PubMed        
    
    
24. MATHEY-ANDREWS N, Rodriguez CL, Shui B, Patriotis AL, et al
    Lineage identity governs oncogene dependence in mouse NSCLC models of KRAS inhibitor resistance.
    Nat Genet. 2026;58:2605-2618.
    PubMed         Abstract available
    
    

    
    PLoS One

25. EL-TANANI M, Satyam SM, Prabhakar S, El-Tanani Y, et al
    Dual targeting of EGFR signaling and microtubule dynamics enhances replication-associated cellular stress and suppresses tumor growth in gefitinib-resistant non-small cell lung cancer.
    PLoS One. 2026;21:e0360164.
    PubMed         Abstract available
    
    
26. MAHDI ZA, AlmjalawI BSA, Naimuzzaman M, Hasan MM, et al
    Investigating the anticancer potential of phytochemicals from the mangrove Rhizophora mucronata as inhibitors of lung cancer-associated proteins: Insights from multiscale computational and in silico analyses.
    PLoS One. 2026;21:e0359525.
    PubMed         Abstract available
    
    
27. JAMIL MA, Awan MDA, Bukhari F, Missen MMS, et al
    EffAtt-LungNet: An attention-guided EfficientNet framework for three-class lung histopathology classification.
    PLoS One. 2026;21:e0359302.
    PubMed         Abstract available
    
    
28. KRISHNAN AR, Kim ME, Gao C, Rudravaram G, et al
    Harmonizing the National Lung Screening Trial: Kernel resolution and field of view compensation.
    PLoS One. 2026;21:e0352075.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

29. WANG N, Padaki R, Thursby SJ, Yen RC, et al
    Chronic cigarette smoke exposure induces distinct stem cell states driving genetic driver-specific non-small cell lung cancer subtypes.
    Proc Natl Acad Sci U S A. 2026;123:e2604393123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum